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Abstract
Background: Cryptorchidism is a frequent syndrome occurring in 1-2% of males within the first year of age.
Autoimmune reactions, particularly directed to testicular elements and/or spermatozoa have been found to be
often associated with cryptorchidism. Therefore we investigated in this study the frequency of HLA class II alleles in
order to recognize possible genetic predisposition for antisperm antibodies development in prepubertal boys with
diagnosed cryptorchidism in Caucasoid population.
Methods: Sixty prepubertal boys with cryptorchidism and sixty healthy boys were examined for anti-sperm antibodies
by indirect immunobead test as well as for their HLA-DRB1 and -DQB1 alleles using DNA obtained from peripheral
blood leukocytes. The typing of HLA-DRB1 and -DQB1 was performed by using PCR-SSP low resolution method.
Results: Allele frequencies of HLA-DRB1 and HLA-DQB1 did not differ between boys with cryptorchidism and control
boys. However, weakly significant differences in DRB1*04 (pc o r r e c t e d= 0.0475) and DQB1*06 (p corrected = 0.0385) were
seen between cryptorchid patients with and without AsA, but none of these two patient groups differed significantly in
HLA class II frequencies from controls except for AsA-negatives and HLA-DQB1*06 (pc o r r e c t e d= 0.0247). On the other
hand, comparison of cryptorchid boys with familial cryptorchidism and/or infertility to control boys revealed highly
significant (pc o r r e c t e d=0 . 0 0 0 6 )d i f f e r e n c ei nHLA-DRB*11 frequency, whereas boys with sporadic cryptorchidism did
not differ from control. A much weaker, but still significant difference in DRB*11 frequency was also observed between
boys with bilateral cryptorchidism and controls (p corrected = 0.037), whereas patients with unilateral cryptorchidism
were not different from control in frequency of any HLA-DRB1 or -DQB1 allele tested.
Conclusions: Predisposition to produce anti-sperm antibodies seems to be only weakly associated with HLA class II
genes, although this question requires further study on much larger population sample. It is plausible that familial
and sporadic cryptorchidism may present distinct genetic background. The same may, to lower extent, apply to
bilateral and unilateral cryptorchidism.
Background
Cryptorchidism is one of the most frequent pathologies
in early childhood (1.4-8.4% in Caucasian term male
births) in which one (unilateral) or both (bilateral) testes
fail to descend into the ideal scrotal position. It is also a
major risk for male infertility and for testicular malig-
nancy in adulthood [1-3]. Genetic factors influencing
susceptibility to cryptorchidism have not been clearly
defined: despite the tendency for a familial aggregation
of cryptorchidism, genetic abnormalities have been
found only in a few patients [4], and several candidate
genes have not been definitely confirmed [5,6].
Many sperm proteins do not arise until spermatogen-
esis starts at puberty. Nevertheless, anti-sperm
* Correspondence: kurpimac@man.poznan.pl
1Institute of Human Genetics Polish Academy of Sciences, Department of
Reproductive Biology and Stem Cells, Strzeszynska 32, 60 479 Poznan,
Poland
Full list of author information is available at the end of the article
Kurpisz et al. Reproductive Biology and Endocrinology 2011, 9:129
http://www.rbej.com/content/9/1/129
© 2011 Kurpisz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.antibodies (AsA) in serum samples from prepubertal
boys were reported [7,8], and our earlier findings
showed that cryptorchidism may play an important role
in antibody formation at this age [9-11]. The human
major histocompatibility complex Class II HLA mole-
cules, by presenting antigens to helper T cells, play a
decisive role in induction of antibody production [12].
Therefore, our aim was to examine whether there is any
HLA class II-associated genetic predisposition for the
development of AsA in prepubertal boys with
cryptorchidism.
Methods
Patients
The study groups consisted of 60 prepubertal boys with
cryptorchidism and 60 healthy boys, age and ethnicity-
matched, from Western Ukraine. Control group under
study was clinically found in good health condition and
was no under vaccination regime when blood samples
were drawn. The local Bioethical Committee of Medical
Lviv University granted the permission for biological
material to be drawn from the subjects for this experi-
mental study. Participants provided a written consent
for including their samples in the study. Characteristic
of the patients is shown in Table 1. Clear recognition
among the studied subgroups was made according to:
sporadic (n = 42), familial (n = 17; one DNA sample
was found not suitable for further studies due to poor
DNA quality), unilateral (n = 40) and bilateral (n = 20)
cryptorchidism. Male infertility was here defined as the
lack of conception in natural procreation conditions for
2 years with maintained regular intercourse within a
couple. Additionally, infertility has been recognized
among the second to the third degree relationship while
familial cryptorchidism was found among the first up to
the third degree of relatives.
Anti-sperm antibody detection - IDIBT (indirect
immunobead test)
Antisperm antibody detection in group with cryptorch-
idism has been performed prior to any surgical interven-
tion and when determining the control population no
positive results according to AsA presence by IDIBT
assay were found.
The procedure has been previously described [10].
Briefly, motile sperm cells were isolated from semen of
AsA-negative donors by swim-up technique. Sperm cells
were washed in HAM F-10 medium supplemented with
1% of bovine serum albumin (BSA) and their concentra-
tion was adjusted to 25-30 × 10
6 per 1 mL. One hun-
dred microliters of this suspension was mixed with 100
μl of a tested sample (serum) and 200 μl of HAM F-10/
BSA, and incubated for 1 hr at 37°C. After incubation,
the cells were washed in HAM F-10/BSA and resus-
pended to a concentration 25-30 × 10
6/mL.
Five microliters of immunobead suspension (5 mg/
ml) were mixed with 10 μl of final sperm suspension,
covered with a coverslip and incubated in a moist
chamber for 8 minutes at room temperature. The sper-
matozoa were observed in a phase-contrast micro-
scope, at 400× magnification. Motile spermatozoa with
at least 1 bead attached to their surface were consid-
ered as positive. Binding of immunobeads to the parti-
cular regions of a sperm cell (head, midpiece, tail) was
also documented.
Genomic DNA isolation
Peripheral blood samples were drawn on EDTA (ethyle-
nediaminetetraacetic acid) and served for extraction of
the genomic DNA. DNA was obtained by using a pro-
teinase K digestion and commercially available DNA
extraction kit (Isoquick Nucleic Extraction Kit, Invitek
GmbH, Berlin, Germany). HLA class II alleles were
typed using the polymerase chain reaction-sequence-
specific primer (PCR-SSP) low resolution method. HLA-
DRB1*, DQB1* typing was performed using the Dynal
DRB1*, DQB1* typing kit (AllSet SSP DRB1, DQB1,
Dynal Biotech.Ltd., Bromborough, UK) following manu-
facturer’s instruction. PCR amplification was performed
using genomic DNA (50 ng/μl), master mix (Dynal Bio-
tech Ltd., Bromborough, UK), Platinum Taq polymerase
(Invitrogen Brazil, 5 U/μl), and primers (24 sets for
HLA-DRB1 and 8 for HLA-DQB1). The amplification
profile consisted of denaturation 96°C (120 sec), next 10
cycles: 96°C (15 sec), 65°C (60 sec), and 20 cycles: 96°C
(10 sec), 61°C (50 sec), 72°C (30 sec). After gel electro-
phoresis of PCR products in 2% agarose in 0.5 × TBE
buffer (15 min at 10 V/cm), UV transilluminator (Vilber
Table 1 Characteristics of patients with cryptorchidism.*
AsA negative AsA 1-10% AsA>10%
total n % n % n %
<1 ano 3 3 100 0 0 0 0
1 a 4 29 17 58,6 7 24,1 5 17,2
5 a 9 16 9 56,3 3 18,8 4 25,0
10 a 14 12 8 66,7 3 25,0 1 8,3
Tanner
P1 56 35 62,5 12 21,4 9 16,1
P2 3 1 33,3 1 33,3 1 33,3
P3 1 1 100,0 0 0,0 0 0,0
1-14 unilateral cryptorchidism AsA (+) 13 65
1-14 bilateral cryptorchidism AsA (+) 7 35
1-14 sporadic cryptorchidism AsA (+) 17 27
1-14 familial cryptorchidism/infertility AsA (+) 3 18
1-14 familial cryptorchidism AsA (+) 3 30
*This cohort of individuals has been excluded from other possible interfering
diseases of inflammatory/immunological nature; also from vaccination
procedures and/or medical treatment.
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obtained amplification pattern.
Statistical analysis
Statistical differences between prepubertal boys with
cryptorchidism and healthy control subjects and among
subgroups of cryptorchid boys were tested using chi-
square analysis including Yates correction, and both
tailed Fisher test as the numbers of patients after subdi-
vision into different clinical categories were rather small.
A level of pcorrected < 0.05 was considered to be
significant.
Results
AsA-positive population of prepubertal boys here identi-
fied (Table 1) has been characterized according to uni-
lateral (majority of cases) and bilateral cryptorchidism as
well as sporadic and familial cases. Certain degree of
surprise was noticed in respect to familial infertility
where the number of positive for AsA case has been
markedly lower (than expected) compared with a group
of familial cryptorchidism. Due to the high specificity of
detection test applied (IBT) there were no AsA positive
individuals in control group under study.
Allele frequencies of HLA-DRB1 and HLA-DQB1 did
not differ between boys with cryptorchidism and control
boys (data not shown). However, weakly significant dif-
ferences in DRB1*04 (pcorrected = 0.0475, O.R. = 0.124)
and DQB1*06 (pcorrected = 0.0385, O.R. = 0.291) were
seen between cryptorchid patients with and without
AsA (Table 2), but none of these two patient groups dif-
fered significantly in HLA class II frequencies from con-
trols (not shown) except for AsA-negative patients and
HLA-DQB1*06 (pcorrected = 0.0247, O.R. = 0.3229, C.I. =
0.1261-0.827).
On the other hand, comparison of cryptorchid boys
with familial cryptorchidism and/or infertility to control
boys revealed highly significant (pcorrected = 0.0006, O.R.
=4 . 3 0 4 )d i f f e r e n c ei nHLA-DRB*11 frequency, whereas
boys with sporadic cryptorchidism did not differ from
control (Table 3). A much weaker, but still significant
difference in DRB*11 frequency was also observed
between boys with bilateral cryptorchidism and controls
(pcorrected = 0.037, O.R. = 3.000), whereas patients with
unilateral cryptorchidism were not different from con-
trol in frequency of any HLA-DRB1 or -DQB1 allele
tested (Table 4).
Discussion
Class II HLA molecules, by presenting antigens to
helper T cells, play a decisive role in induction of anti-
body production [12]. Therefore, we expected to find an
association of some HLA-DRB1 or -DQB1 allele(s) with
the presence of anti-sperm antibodies in our patients.
To our surprise, relatively weak associations were
detected, showing a protective effect of HLA-DRB1*04
Table 2 Comparison of HLA-DRB1 and -DQB1 allele frequencies in anti-sperm antibody (AsA)-positive and -negative
patients with cryptorchidism
Allele HLA-DRB1/DQB1 AsA negative
N=3 7
AsA positive
N=2 3
% (N) % (N) p/pc OR C.I
DRB1* 01 14 (10) 17 (7)
DRB1* 15 7 (5) 15 (6)
DRB1* 16 7 (5) 0 (0)
DRB1* 03 10 (7) 10 (4)
DRB1* 04 17 (12) 2,5 (1) 0.0221/0.0475 0.1239 0.01548- 0.9925
DRB1* 11 16 (11) 20 (8)
DRB1* 12 1,5 (1) 5 (2)
DR B1*13 10 (7) 10 (4)
DR B1*14 3 (2) 2,5 (1)
DRB1* 07 13 (9) 10 (4)
DRB1* 08 1,5 (1) 2,5 (1)
DRB1* 09 0 (0) 5 (2)
DRB1* 10 0 (0) 0 (0)
DQB1* 02 21 (15) 20 (8)
DQB1* 03 43 (30) 32 (13)
DQB1* 04 0 (0) 0 (0)
DQB1* 05 27 (19) 22 (9)
DQB1* 06 9 (6) 25 (10) 0.0187/0.0385 0.2813 0.09349-0.8461
pc = p corrected
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and in control individuals
Allele HLA-DRB1/D Controls
N=6 0
Cryptorchidism
Familial
N=1 7
Sporadic
N=4 2
p/pc OR C.I.
% (N) % (N) % (N)
DRB1* 01 9 (11) 6 (2) 18 (15)
DRB1* 15 10 (12) 9 (3) 12 (10)
DRB1* 16 6 (7) 3 (1) 5 (4)
DRB1* 03 8 (10) 15 (5) 11 (9)
DRB1* 04 12 (14) 15 (5) 11 (9)
DRB1* 11 10 (12)* 32 (11)* 12 (10) *0.0012/0.0031 4.304 1.692-10.95
DRB1* 12 3 (4) 6 (2) 1 (1)
DR B1*13 15 (18) 6 (2) 12 (10)
DR B1*14 5 (6) 3 (1) 2 (2)
DRB1* 07 12 (15) 6 (2) 12 (10)
DRB1* 08 7 (9) 0 0 2 (2)
DRB1* 09 0 (0) 0 0 2 (2)
DRB1* 10 2 (2) 0 0 0 0
DQB1* 02 18 (22) 18 (6) 21 (18)
DQB1* 03 31 (37) 50 (17) 32 (27)
DQB1* 04 5 (6) 0 0 0 0
DQB1* 05 23 (28) 18 (6) 29 (24)
DQB1* 06 22 (27) 15 (5) 18 (15)
Table 4 Comparison of HLA-DRB1 and -DQB1 allele frequencies in patients with bilateral and unilateral cryptorchidism
and in control individuals
Allele HLA-DRB1/DQB1 Controls
N=6 0
Cryptorchidism
Bilateral
N=2 0
Unilateral
N=4 0
p/pc OR C.I.
% (N) % (N) % (N)
DRB1* 01 9 (11) 15 (6) 15 (12)
DRB1* 15 10 (12) 7,5 (3) 14 (11)
DRB1* 16 6 (7) 2,5 (1) 5 (4)
DRB1* 03 8 (10) 5 (2) 14 (11)
DRB1* 04 12 (14) 10 (4) 11 (9)
DRB1* 11 10 (12)* 25 (10)* 13 (10) *0.0171/0.0369 3.000 1.181-7.617
DRB1* 12 3 (4) 2,5 (1) 2,5 (2)
DR B1*13 15 (18) 10 (4) 10 (8)
DR B1*14 5 (6) 2,5 (1) 2,5 (2)
DRB1* 07 12 (15) 12,5 (5) 10 (8)
DRB1* 08 7 (9) 2,5 (1) 1,3 (1)
DRB1* 09 0 0 5 (2) 0 0
DRB1* 10 2 (2) 0 0 0 0
DQB1* 02 18 (22) 17,5 (7) 23 (18)
DQB1* 03 31 (37) 45 (18) 32 (25)
DQB1* 04 5 (6) 0 0 0 0
DQB1* 05 23 (28) 20 (8) 31 (24)
DQB1* 06 22 (27) 17,5 (7) 19 (15)
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AsA
+ and 37 AsA
- individuals), this result should be
confirmed in a study of much higher number of cryp-
torchid patients and controls. Further to that we have to
note the lack of homogeneity between compared control
and tested populations illustrated at different degree of
Tanner stage assigned to sexual development (see, Table
1) for both groups (AsA
+ versus AsA
-). As the results
listed do not indicate classical way of antisperm anti-
body induction along the affinity maturation (more
advanced Tanner stage sexual maturity more antibodies
should be elicited) we may only point out that popula-
tion under study consisted of only 1 individual at Tan-
ner stage 2 and virtually no individuals at Tanner stage
3. Antisperm antibody induction in individuals with no
sperm present has been clearly shown in proteomic
approach to be induced mainly by cross-reactive testicu-
lar tissue elements [13].
We have not found any association of HLA class II
alleles with cryptorchidism itself. So far, associations of
cryptorchidism with some HLA-DRB1 and HLA-DQB1
alleles, very rare in Caucasians, were described only for
a Japanese population [14], whereas no correlation with
HLA class II polymorphism was observed in a study on
Northern Italian Caucasians [15]. Interestingly, this lat-
ter study reported some associations of HLA class I
alleles (HLA-A11, -A23 and -A29), possibly explained by
their crossreactivity with receptors for LH and hCG pre-
sent on fetal Leydig cells and interference with the hor-
mone-binding site through a mechanism of ‘molecular
mimicry’ [15].
On the other hand, we obtained an unexpected find-
ing of a strong difference between familial (but not
sporadic) cryptorchidism (and/or with history of inferti-
lity within these families) and healthy controls, showing
ah i g hr i s kf o rHLA-DRB1*11 bearers. This result may
s u g g e s tt h a ts p o r a d i ca n df a milial cryptorchidism may
have different genetic background. HLA-DRB1*11 was
also, albeit weakly, associated with bilateral cryptorchid-
ism. Again, this finding should be confirmed on a larger
population sample.
In summary, predisposition to produce anti-sperm
antibodies seems to be only weakly associated with HLA
class II genes, although this question requires further
study on much larger population sample. It is plausible
that familial and sporadic cryptorchidism may present
distinct genetic background. The same may, to lower
extent, apply to bilateral and unilateral cryptorchidism.
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